source
- Neurocrine’s rare-disease drug approved but later linked to deaths and serious side effectsNeurocrine Biosciences received regulatory approval for a rare‑disease therapy after a small clinical trial showed modest efficacy and side effects that were considered manageable. The decision was…
- STAT+: As young people increasingly get cancer, new fertility options are changing their futuresNew technologies, cancer doctors, and reproductive specialists are working to give more patients a chance to have children post-treatment.STAT · 3h ago↗ source